In Africa, glaucoma presents a uniquely difficult problem, as its high prevalence is compounded by economic barriers to essential medical care.
Selective laser trabeculoplasty (SLT) is a potentially transformative modality in this setting, presenting an opportunity for quick, safe, and effective long-term treatment.
During a trip to Togo, West Africa, Dr.Shlomo Melamed, MD and his colleagues taught local ophthalmologists to perform SLT using Digital Duet.
After 6 months with Lumenis’ Digital Duet SLT-YAG system, Thomas Castillo, DO, details his experience with the system, receiving exceptional clarity, reimbursable imaging and robust clinical results.
Western University of Health Sciences College of Optometry partners with Lumenis to train students in Digital Duet, the first digital SLT-YAG and cutting-edge OptiLight treatments.
Weighing first-line therapies for glaucoma? Dr. Kristin O. Chapman explains how to answer the question: Should you prescribe drops first or start with SLT?
With Selecta Duet, Dr. Nate Radcliffe controls IOP without frequent visits and often without medication—two clear advantages during COVID-19 lockdowns.
In an interactive webinar, Dr. Nate Lighthizer discusses Lumenis SLT’s advantages for glaucoma patients and referral decisions for this trusted laser treatment.
Dr. Kristin O. Chapman explains how SLT’s promotion to first-line therapy is changing the age-old battle for glaucoma drop tolerance and adherence.
Dr. Nate Radcliffe shares how Lumenis SLT is a cost-effective first-line approach for patients with glaucoma in this video from ASCRS San Diego.
